ImmuPharma plc (AIM:IMM)
London
· Delayed Price · Currency is GBP · Price in GBX 4.200
-0.400 (-8.70%)
Feb 21, 2025, 4:54 PM GMT+1
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 17.49 million as of February 21, 2025. Its market cap has increased by 230.71% in one year.
Market Cap
17.49M
Enterprise Value
16.41M
Revenue
-69.96K
Ranking
n/a
PE Ratio
n/a
Stock Price
4.20
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 17.49M, a decrease of -51.57%. That is a compound annual growth rate of -3.74%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.71B |
| GSK plc | 59.06B |
| Haleon | 34.94B |
| Smith & Nephew | 8.87B |
| Hikma Pharmaceuticals | 5.06B |
| ConvaTec Group | 4.94B |
| HUTCHMED (China) | 2.06B |
| Oxford Nanopore Technologies | 1.26B |